Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: An in vitro study

Journal of Periodontology

Volumn 75, Issue 10, 2004, Pages 1327-1334

  Eick, Sigrun ^a   Pfister, Wolfgang ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Antibiotics therapeutic use; Cells; Epithelial; Periodontal diseases microbiology; Periodontal diseases pathology

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DOXYCYCLINE; METRONIDAZOLE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIOPLANKTON; CONTROLLED STUDY; DRUG EFFICACY; EPITHELIUM CELL; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERIODONTAL DISEASE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; STREPTOCOCCUS CONSTELLATUS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CLINDAMYCIN; COLONY COUNT, MICROBIAL; DOXYCYCLINE; HUMANS; INTRACELLULAR SPACE; KB CELLS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PERIODONTITIS; PERIODONTIUM; PORPHYROMONAS GINGIVALIS; QUINOLINES; STREPTOCOCCUS CONSTELLATUS; TIME FACTORS;

EID: 8744259752     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2004.75.10.1327     Document Type: Article

References (37)

1. Genco RJ, Kornman K, Williams R, et al. Consensus report periodontal diseases: Pathogenesis and microbial factors. Ann Periodontol 1996;1:926-932.
2. Potempa J, Pike R, Travis J. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun 1995;63: 1176-1182.
3. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol 2003;74:111-118.
4. Fives-Taylor PM, Meyer DH, Mintz KP, Brisette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999;20:136-167.
5. Socransky SS, Haffajee AD, Smith C, Duff GW. Microbial parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol 2000;27: 810-818.
6. Schytte Blix IJ, Hars R, Preus HR, Helgeland K. Entrance of Actinobacillus actinomycetemcomitans into Hep-2 cells in vitro. J Periodontol 1992;63:720-728.
7. Duncan MJ, Nakao S, Skobe Z, Xie H. Interactions of Porphyromonas gingivalis with epithelial cells. Infect Immun 1993;61:2260-2265.
8. Sandros J, Papapanou PN, Nannmark U, Dahlen G. Porphyromonas gingivalis invades human pocket epithelium in vitro. J Periodontal Res 1994;29:62-69.
9. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1995;63:3878-3885.
10. Meyer DH, Lippmann JE, Fives-Taylor PM. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: A dynamic, multistep process. Infect Immun 1996;64: 2988-2997.
11. Eick S, Rödel J, Einax JW, Pfister W. Interaction of Porphyromonas gingivalis with KB cells - Comparison of different clinical isolates. Oral Microbiol Immunol 2002;17: 201-208.
12. Madianos PN, Papapanou PN, Nannmark U, Dahlen G, Sandros J. Porphyromonas gingivalis FDC381 multiplies and persists within oral epithelial cells in vitro. Infect Immun 1996;64:660-664.
13. Houalet-Jeanne S, Pellen-Mussi P, Tricot-Doleux, Apiou J, Bonnaure-Mallet M. Assessment of internalization and viability of Porphyromonas gingivalis in KB epithelial cells by confocal microscopy. Infect Immun 2001;69: 7146-7151.
14. Rudney JD, Chen R, Sedgewick GJ. Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun 2001;69:2700-2707.
15. Bollen CML, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. J Periodontol 1996;67: 1143-1158.
16. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol 2002;73:1267-1272.
17. Pfister W, Eick S, Assefa S. Activity of quinolones against anaerobic and capnophilic bacteria in vitro (in German). Dtsch Zahnärztl Z 2001;56:189-192.
18. Yumoto H, Nakae H, Fujinaka K, Ebisu S, Matsuo T. Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathogenic Eikenella corrodens. Infect Immun 1999;67: 384-394.
19. Hand WL, King-Thompson NL. Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts. Antimicrob Agents Chemother 1990;34:1189-1193.
20. van den Broek PJ. Activity of antibiotics against microorganisms ingested by mononuclear phagocytes. Eur J Clin Microbiol Infect Dis 1991;10:114-118.
21. Pascual A, Garcia I, Ballesta S, Perea EJ. Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cells. Antimicrob Agents Chemother 1999;43(1):12-15.
22. Brayton JJ, Yang Q, Nakkula RJ, Walters JD. An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells. J Periodontol 2002;73:1267-1272.
23. Ahren IL, Karlsson E, Forsgren A, Riesbeck K. Comparison of the antibacterial activities of ampicillin, ciprofloxacin, clarithromycin, telithromycin and quinopristin/dalfopristin against intracellular non-typeable Haemophilus influenzae. J Antimicrob Chemother 2002;50: 903-906.
24. Meyer DH, Rose JE, Lippmann JE, Fives-Taylor PM. Microtubules are associated with intracellular movement and spread of the periodontopathogen Actinobacillus actinomycetemcomitans. Infect Immun 1999;67:6519-6225.
25. Fletcher J, Reddi K, Poole S, et al. Interactions between periodontopathogenic bacteria and cytokines. J Periodontal Res 1997;32:200-205.
26. Uchida Y, Shiba H, Komatsuzawa H, et al. Expression of IL-1β and IL-8 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Cytokine 2001;14:152-161.
27. Darveau RP, Belton CM, Reife RA, Lamont RJ. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 1998;66: 1660-1665.
28. Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J. Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun 1999; 11:598-602.
29. von Troil-Linden B, Saarela M, Matto J, Alaluusa S, Jousimies-Somer H, Asikainen S. Source of suspected periodontal pathogens re-emerging after periodontal treatment. J Clin Periodontol 1996;23:601-607.
30. Mombelli A, Schmid B, Rutar A, Lang NP. Local antibiotic therapy guided by microbiological diagnosis. Treatment of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans persisting after mechanical therapy. J Clin Periodontol 2002;29:743-749.
31. Walz A, Nichterlein T, Hof H. Excellent activity of newer quinolones on Legionella pneumophila in J774 macrophages. Zentralbl Bakteriol 1997;285:431-439.
32. Phanucharas JP, Gorby GL. Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture. Antimicrob Agents Chemother 1997;41:1547-1551.
33. Stass H, Dalhoff A, Kubitza D, Schühly U. Pharmacokinetics, safety and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects. Antimicrob Agents Chemother 1998; 42:2060-2065.
34. Harrel SK, Nunn ME. Longitudinal comparison of the periodontal status of patients with moderate to severe periodontal disease receiving no treatment, non-surgical treatment, and surgical treatment utilizing individual sites for analysis. J Periodontol 2001;72:1509-1519.
35. Hand WL, King-Thompsen NL. The entry of antibiotics into human monocytes. J Antimicrob Chemother 1989; 23:681-689.
36. Adamsson I, Nord CE, Lundquist P, Sjostedt S, Edlund C. Comparative effects of omeperazole, amoxicillin plus metronidazole versus omeperazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother 1999;44:629-640.
37. Pavicic MJAMP, van Winkelhoff AJ, de Graaff J. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother 1992;36:2634-2638.